Flow cytometric analysis of Human CD36 expression on human peripheral blood. Human peripheral blood was stained with Brilliant Violet 605™ Mouse Anti-Human HLA-DR Antibody and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Left panel) or SDT Alexa Fluor® 647 Mouse anti-Human CD36 Antibody (Right panel) at 5μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Alexa Fluor® 647 Mouse Anti-Human CD36 Antibody (S-R617)
Alexa Fluor® 647 Mouse Anti-Human CD36 Antibody (S-R617)
Price:
Regular price
$110 USD
Regular price
Sale price
$110 USD
Unit price
per
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details
Product Details
Product Details
Product Specification
| Host | Mouse |
| Antigen | CD36 |
| Synonyms | Platelet glycoprotein 4; Fatty acid translocase (FAT); Glycoprotein IIIb (GPIIIB); Leukocyte differentiation antigen CD36; PAS IV; PAS-4; Platelet collagen receptor; Platelet glycoprotein IV (GPIV); Thrombospondin receptor; GP3B; GP4 |
| Location | Cell membrane |
| Accession | P16671 |
| Clone Number | S-R617 |
| Antibody Type | Mouse mAb |
| Isotype | IgG1,k |
| Application | FCM |
| Reactivity | Hu |
| Positive Sample | human peripheral blood |
| Purification | Protein G |
| Concentration | 0.05mg/ml |
| Conjugation | Alexa Fluor® 647 |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 25% Glycerol, 1% BSA, 0.3% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
| application | dilution | species |
| FCM | 5μl per million cells in 100μl volume | Hu |
Background
CD36 is a transmembrane glycoprotein that serves as a key fatty acid transporter and sensor, playing a crucial role in lipid metabolism. It is involved in the recognition and phagocytosis of lipids by macrophages and has been implicated in inflammatory responses and cardiovascular diseases. CD36 is also expressed in various immune cells and has been shown to regulate autophagy. Additionally, it is highly expressed in several types of cancer, where it promotes tumor progression by facilitating fatty acid uptake, epithelial-mesenchymal transition (EMT), and resistance to anticancer drugs. CD36 has emerged as a potential therapeutic target for metabolic diseases, cardiovascular conditions, and cancer.
Picture
Picture
FC
